Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer Receives European Approval for Herceptin Biosimilar, Trazimera
Pfizer Receives European Approval for Herceptin Biosimilar, Trazimera
Pfizer Receives European Approval for Herceptin Biosimilar, Trazimera
Submitted by
admin
on July 31, 2018 - 12:30pm
Source:
CP Wire
News Tags:
Ttrazimera
Pfizer
biosimilars
Herceptin
Europe
Roche
Headline:
Pfizer Receives European Approval for Herceptin Biosimilar, Trazimera
snippet:
Ttazimera is Pfizer's first therapeutic oncology biosimilar to receive a positive CHMP opinion from the EMA.
Herceptin brought in $2.5 billion in the US alone in 2016
Do Not Allow Advertisers to Use My Personal information
